{
  "patient_id": "48367792",
  "processing_timestamp": "2025-08-12T19:13:16.618909",
  "guideline_version": "ADA 2023",
  "clinical_alerts": [
    {
      "message": "Prediabetes diagnosed: A1C 6.4% (5.7-6.4%)",
      "priority": "warning",
      "category": "prevention",
      "evidence": "ADA 2023 Table 2.2: A1C 5.7-6.4% diagnostic for prediabetes",
      "action_required": true,
      "guideline_reference": "ADA 2023 Section 3"
    },
    {
      "message": "Prediabetes: Fasting glucose 102.6 mg/dL (100-125)",
      "priority": "warning",
      "category": "prevention",
      "evidence": "ADA 2023 Table 2.2: FPG 100-125 mg/dL diagnostic for prediabetes",
      "action_required": true,
      "guideline_reference": ""
    },
    {
      "message": "Low HDL cholesterol 1.37 mg/dL",
      "priority": "info",
      "category": "cardiovascular",
      "evidence": "Low HDL increases cardiovascular risk",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Diabetes Self-Management Education and Support (DSMES) referral recommended",
      "priority": "info",
      "category": "education",
      "evidence": "ADA 2023 Section 5.2: DSMES at diagnosis and annually",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Medical Nutrition Therapy (MNT) referral recommended",
      "priority": "info",
      "category": "lifestyle",
      "evidence": "ADA 2023 Section 5: MNT by registered dietitian",
      "action_required": false,
      "guideline_reference": ""
    },
    {
      "message": "Physical activity: \u2265150 min/week moderate-intensity aerobic activity",
      "priority": "info",
      "category": "lifestyle",
      "evidence": "ADA 2023 Section 5.29: Physical activity recommendations",
      "action_required": false,
      "guideline_reference": ""
    }
  ],
  "medication_recommendations": [
    {
      "medication_class": "Metformin",
      "specific_agents": [
        "metformin immediate-release"
      ],
      "rationale": "Diabetes prevention in high-risk prediabetes",
      "contraindications": [
        "eGFR <30",
        "Metabolic acidosis"
      ],
      "monitoring_required": [
        "Kidney function",
        "Gastrointestinal tolerance"
      ],
      "ada_reference": "ADA 2023 Section 3.6"
    }
  ],
  "treatment_goals": [
    {
      "parameter": "Preprandial glucose",
      "target_value": "80-130 mg/dL",
      "rationale": "ADA 2023 standard preprandial target",
      "priority": "standard"
    },
    {
      "parameter": "Postprandial glucose",
      "target_value": "<180 mg/dL",
      "rationale": "ADA 2023 standard postprandial target",
      "priority": "standard"
    }
  ],
  "summary": "1 medication recommendations; 2 individualized treatment targets",
  "next_actions": [
    "Review and initiate appropriate diabetes medications",
    "Refer for diabetes education and lifestyle interventions"
  ]
}